|
The WHCMAA is excited to mark a major milestone…… the 10-year anniversary of the Wharton Healthcare Quarterly. We will be “Celebrating the Past and Embracing the Future” throughout the year.
Please join us for the next event in our monthly webinar series with Suchismita Das, Healthcare and Life Sciences Industry Analyst, Frost & Sullivan and Reenita Das, Healthcare and Life Sciences Partner and Senior Vice President, Frost & Sullivan. The pandemic and healthcare crises resulted in digital health taking centre stage. A positive consequence of this was the rise of female technology and more debate and discussion around gender-specific health. So far, women’s health has usually been relegated to being within the folds of reproductive health. From stroke and diabetes to prosthetic implants and mental health issues, women have long been suffering from receiving care and treatment that has been designed “for men, by men, and on men.” In the era of precision health, we need to acknowledge that it is time for women to receive gender-specific treatment and care.
While the FemTech market is still in a nascent stage, it has witnessed considerable innovations in the recent past, with the emergence of newer digital solutions across all segments ranging from fertility monitoring to cancer diagnosis solutions. The increasing focus on providing holistic personalized care for women of all ages beyond fertility and pregnancy care, menopause unveils itself as the next big opportunity in the global FemTech landscape. Come and join us in unveiling the huge growth opportunities in FemTech that would eventually improve the life of the “world’s better-half.”
Femtech Comes out of the Shadows: Growth Opportunities for 2025 and the Future of Gender Specific Healthcare
Wednesday, July 13, 2022
12:00pm - 1:00pm ET
Register Here
Registration deadline:
Wednesday, July 13th at 10:00am ET
Suchismita Das
Healthcare and Life Sciences Industry Analyst, Frost & Sullivan
Suchismita Das has over ten years of expertise in market research and custom consulting spanning across different industries including electronics and security, FMCG, manufacturing, renewable energy and healthcare. In her current role, Das has successfully authored many research studies on different healthcare areas including:
- Impact of Mergers & Acquisitions in Medtech
- Automated Endoscope Reprocessors
Her studies primarily spans around in-depth analysis on technologies with focus on next-generation technologies revolutionizing the healthcare space.
Additionally, she works on identifying industry best practices and mapping of core capabilities, mega trends and understanding the challenges of the complex business scenario and how to address them, and also identifying opportunities outside the healthcare space to include them effectively in the healthcare domain. Her specialization in medical devices and medical technologies enables her in enhancing her industry analysis studies backed with insights collected from key industry stakeholders.
Reenita Das
Healthcare and Life Sciences Partner and Senior Vice President, Frost & Sullivan
Reenita Das is a healthcare futurist and strategist, passionate about changing the healthcare industry. She was voted the top 100 women in Femtech and Healthtech and the top 50 Healthcare strategists to follow in 2021. She has lived and worked in over 10 countries in the world, focusing on healthcare issues and working with public and private sector to implement growth change strategies. Das currently serves as Partner and Senior Vice President and is the first woman Partner at Frost & Sullivan. In addition, she is the Founder of GLOW (Growth and Innovation of Women) program. She is also on the Board of a non profit “High Tech High Heels” Silicon Valley that focuses on increasing gender diversity for STEM. She is also part of the Advisory Board in Arab Health.
In her current role, Das manages a global business and works largely with clients on futuristic scenarios and forecasts in understanding how healthcare will operate 20 years from today. She is focused heavily on rethinking consumer business models as healthcare makes a transition to health and identifying opportunities with companies outside of healthcare to bring solutions to the healthcare sector. She is also focusing heavily on showcasing “Femtech” and the growth opportunities from this new sector which includes advising femtech companies on the right strategies and commercial business models to success.
Fees and Registration:
Participation is free to Dues-Paying Members of the WHCMAA and Current WHCM Program Students (join or renew here).
Non-members are welcome to participate for a $20 fee.
Danna Daughtry - Club Administrator
customerservice@whartonhealthcare.org
|
